Keywords
Bone cancer
Breast Cancer
General Oncology
Gynecological Cancers
Head and neck cancer
Lung Cancer
Radiation Oncology
Correspondence to Author: Laria Santo de Sousa,
State University of Bahia, Brazil
Abstract:
This critique goes through several researches supported the effectiveness of the neurochemical monoamine neurotransmitter on cancer cells and additionally the impact of SSRIs (selective monoamine neurotransmitter uptake inhibitors) medication on the explanation for sure kinds of cancers. monoamine neurotransmitter has been shown to be a agent issue for a large vary of traditional and growth cells. In distinction, low doses of monoamine neurotransmitter will inhibit growth growth via the decrease of blood offer to the growth, suggesting that the role of monoamine neurotransmitter on growth growth is concentration-dependent. bodily fluid monoamine neurotransmitter level was found to be appropriate for prognosis analysis of urothelial cancer within the bladder, {adenocarcinoma|glandular cancer|glandular cancer|carcinoma} of the prostate and excretory organ cell carcinoma.The mechanism that connect monoamine neurotransmitter with growth evolution appear to be associated with the monoamine neurotransmitter impact on growth associated macrophages.
Citation:
Laria Santo de Sousa. The Impact of the 5-hydroxytryptamine on the Cause and Treatment of Cancer. World Journal of Medical Oncology 2020.
Journal Info
- Journal Name: World Journal of Medical Oncology
- Impact Factor: 2.709**
- ISSN: 2766-6077
- DOI: 10.52338/wjoncgy
- Short Name: WJMOY
- Acceptance rate: 55%
- Volume: 6 (2024)
- Submission to acceptance: 25 days
- Acceptance to publication: 10 days
INDEXING
OUR PUBLICATION BENEFITS
- International Reach
- Peer Review
- Rapid Publication
- Open Access
- High Visibility